Nanosphere (Nanosphere) ROCE % : -145.04% (As of Mar. 2016)

View and export this data going back to 2007. Start your Free Trial

What is Nanosphere ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Nanosphere's annualized ROCE % for the quarter that ended in Mar. 2016 was -145.04%.

Nanosphere ROCE % Historical Data

The historical data trend for Nanosphere's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanosphere ROCE % Chart

Nanosphere Annual Data

Trend

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

ROCE %

Get a 7-Day Free Trial

-76.88

-74.18

-70.88

-94.75

-122.37

Nanosphere Quarterly Data
	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16
ROCE %	Get a 7-Day Free Trial															-125.39	-145.48	-169.16	-116.04	-145.04

Nanosphere ROCE % Calculation

Nanosphere's annualized ROCE % for the fiscal year that ended in Dec. 2015 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2015 )		(A: Dec. 2014 )		(A: Dec. 2015 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2015 )		(A: Dec. 2014 )		(A: Dec. 2015 )
	=	-27.692	/	( ( (42.339 - 15.659)	+	(40.63 - 22.05) )	/ 2 )
	=	-27.692	/	( (26.68	+	18.58)	/ 2 )
	=	-27.692	/	22.63
	=	-122.37 %

Nanosphere's ROCE % of for the quarter that ended in Mar. 2016 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2016 )		(Q: Dec. 2015 )		(Q: Mar. 2016 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2016 )		(Q: Dec. 2015 )		(Q: Mar. 2016 )
	=	-22.388	/	( ( (40.63 - 22.05)	+	(39.785 - 27.493) )	/ 2 )
	=	-22.388	/	( ( 18.58	+	12.292 )	/ 2 )
	=	-22.388	/	15.436
	=	-145.04 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2016) EBIT data.

Nanosphere (NAS:NSPH) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Nanosphere ROCE % Related Terms

Thank you for viewing the detailed overview of Nanosphere's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanosphere (Nanosphere) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Nanosphere Inc (NAS:NSPH) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.nanosphere.us

Nanosphere, Inc., was incorporated in 1999 in Delaware. The Company develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene System, that enables sensitive genomic and protein testing on a single platform. The Verigene System includes a bench-top molecular diagnostics workstation that is an advanced platform for genomic and protein testing. The Verigene System includes a bench-top molecular diagnostics workstation that is a universal platform for genomic and protein testing. The Verigene System provides lower cost for laboratories already performing molecular diagnostic testing and enables smaller laboratories and hospitals without advanced diagnostic capabilities to perform genetic testing.

Executives

Michael James Ward	director	440 W. ONTARIO ST., CHICAGO IL 60654
Lorin Randall	director	C/O ACORDA THERAPEUTICS, INC., 420 SAW MILL RIVER ROAD, ARDSLEY NY 10502
R. Erik Holmlin	director	4088 COMMERCIAL AVE., NORTHBROOK IL 60062
Gene S Cartwright	director	4088 COMMERCIAL AVE, NORTHBROOK IL 60062
Mmcap International Inc. Spc	10 percent owner	C/O MOURANT GOVERNANCE SVCS (CAYMAN) LTD, 94 SOLARIS AVE., CAMANA BAY, PO BOX 1348, GRAND CAYMAN E9 KY1-1108
Ann Wallin	officer: Interim CFO	4088 COMMERCIAL AVENUE, NORTHBROOK IL 60062
Bruin Andre De	director
Sheli Z Rosenberg	director	C/O EQUITY GROUP INVESTMENTS, L.L.C., TWO NORTH RIVERSIDE PLAZA, SUITE 600, CHICAGO IL 60606
Chad A. Mirkin	director	4088 COMMERCIAL AVENUE, NORTHBROOK IL 60062
Brookside Capital Management Llc	10 percent owner	C/O BAIN CAPITAL PUBLIC EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02116
Brookside Capital Partners Fund Lp	10 percent owner	C/O BAIN CAPITAL PUBLIC EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02116
Brookside Capital Investors L P	10 percent owner	C/O BAIN CAPITAL PUBLIC EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Venture Fund 2005, L.p.	10 percent owner	C/O BAIN CAPITAL, LLC, JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Venture Partners 2005, L.p.	10 percent owner	C/O BAIN CAPITAL, LLC, JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Venture Investors, Llc	10 percent owner	200 CLARENDON STREET, BOSTON MA 02116

Nanosphere (Nanosphere) Headlines

From GuruFocus

NANOSPHERE, INC. Reports Operating Results (10-Q)

By gurufocus • 05-08-2009

NANOSPHERE, INC. Reports Operating Results (10-Q)

By gurufocus 10qk • 08-05-2010

NANOSPHERE, INC. Reports Operating Results (10-Q)

By gurufocus 10qk • 05-06-2010

NANOSPHERE, INC. Reports Operating Results (10-Q)

By gurufocus 10qk • 11-05-2009

New Optical Disks May Boost the Gold Nanoparticles Industry

By Alberto Abaterusso Alberto Abaterusso • 03-27-2018